Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cognitive effects of three new antiepileptic drugs examined

April 23, 1999

Fujisawa, Quark collaborate on genomics research in the area of stroke

April 22, 1999

Taro evaluates anticonvulsant barbiturate compounds in dog model

April 22, 1999

Aminomethyl benzofuran-based compounds as potent and selective 5-HT1A receptor ligands

April 22, 1999

News from FASEB: CT-3 is a potent and long-acting analgesic with good tolerability

April 22, 1999

DuPont patents new series for suppressing CRF hypersecretion and/or treating anxiogenic disorders

April 21, 1999

Neurogen describes novel brain GABA-A receptor ligands

April 21, 1999

Kosan awarded NIH grant for neuroregenerative agent discovery

April 21, 1999

Potent and selective 5-HT1B/5-HT1D receptor agonists in the pipeline at Pierre Fabre

April 20, 1999

Preclinical study supports antinociceptive efficacy of ET-A antagonist

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...